ATOPIC DERMATITIS ECZEMA

This study looks at whether people with well-controlled eczema can safely extend the time between their dupilumab injections from every 2 weeks to every 3 or 4 weeks. About 216 adults with controlled atopic dermatitis will be randomly assigned to one of three dosing schedules. Re…

This study tests an experimental drug called IMG-007 for adults with moderate-to-severe eczema (atopic dermatitis) that hasn't responded well to topical treatments. About 220 participants will receive either IMG-007 or a placebo to see if the drug safely reduces skin symptoms lik…

This study tests a new daily pill called soquelitinib for adults with moderate to severe eczema (atopic dermatitis). Researchers want to see if it reduces skin redness, itching, and rash better than a placebo. About 200 participants will take the pill or a dummy pill for 12 weeks…

This study looks at how the skin of people with moderate-to-severe eczema changes when they are treated with tralokinumab. Researchers will use a special, non-invasive microscope to see the skin's structure in detail. The goal is to better understand how the treatment works on a …

This study looks at whether tiny DNA pieces in the blood, called cell-free DNA, can show how active eczema is. Researchers will compare these levels in people with eczema and healthy volunteers, and check how skin immune cells react. The goal is to find a simple blood test to mon…